Key result
Senecavirus A 2B and 3C proteins antagonize the antiviral activity of host protein DDX21 by inducing its degradation via the caspase pathway to promote viral replication.
Why the study?
Senecavirus A replicates efficiently in cells, but the molecular mechanisms facilitating this replication remain poorly understood.
This study reveals a mechanism of viral evasion where Senecavirus A uses its 2B and 3C proteins to degrade the host antiviral factor DDX21 via the caspase pathway.
DDX21 merits functional validation as a host factor in SVA; leaves open its therapeutic targeting in swine virology.
Senecavirus A (SVA), also known as Seneca Valley virus, is a recently discovered picornavirus that can cause swine vesicular disease, posing a great threat to the global swine industry. It can replicate efficiently in cells, but the molecular mechanism remains poorly understood. This study determined the host's differentially expressed proteins (DEPs) during SVA infection using dimethyl labeling based on quantitative proteomics. Among the DE proteins, DDX21, a member of the DEAD (Asp-Glu-Ala-Asp)-box RNA helicase (DDX) family, was downregulated and demonstrated inhibiting SVA replication by overexpression and knockdown experiment. To antagonize this antiviral effect of DDX21, SVA infection induces the degradation of DDX21 by 2B and 3C proteins. The Co-IP results showed that 2B and 3C did not interact with DDX21, suggesting that the degradation of DDX21 did not depend on their interaction. Moreover, the 3C protein protease activity was necessary for the degradation of DDX21. Furthermore, our study revealed that the degradation of DDX21 by 2B and 3C proteins of SVA was achieved through the caspase pathway. These findings suggest that DDX21 was an effective antiviral factor for suppressing SVA infection and that SVA antagonized its antiviral effect by degrading DDX21, which will be useful to guide further studies into the mechanism of mutual regulation between SVA and the host.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2022) studied Senecavirus A (SVA) infection. Senecavirus A (SVA) infection and viral proteins 2B and 3C vs. Mock infection / control cells was evaluated on DDX21 protein expression and viral replication (TCID50). Senecavirus A 2B and 3C proteins antagonize the antiviral activity of host protein DDX21 by inducing its degradation via the caspase pathway to promote viral replication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: